Innoven Partenaires
English
Français
Access to professionals and Distributors
Home
Presentation
Our approach
Portfolio
Our funds
Subscribers
Contact us
Innoven-Partenaires
>>
News
>>
News
>>
2008-09-23 Arpida completes enrolment in PhaseII “intravenous to oral” switch trial with oral Iclaprim
News
Retour
23/09/2008
2008-09-23 Arpida completes enrolment in PhaseII “intravenous to oral” switch trial with oral Iclaprim
ARPIDA COMPLETES ENROLMENT IN PHASE II “INTRAVENOUS-TO-ORAL” SWITCH TRIAL WITH ORAL ICLAPRIM
Précédent
Suivant